TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 48 filers reported holding TELA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,681,489 | -18.7% | 335,145 | +2.9% | 0.00% | – |
| Q2 2023 | $3,299,300 | +232.5% | 325,696 | +249.3% | 0.00% | – |
| Q1 2023 | $992,233 | +104676.5% | 93,255 | +13.2% | 0.00% | – |
| Q4 2022 | $947 | -99.8% | 82,412 | +20.1% | 0.00% | – |
| Q3 2022 | $584,000 | +20.2% | 68,620 | +0.4% | 0.00% | – |
| Q2 2022 | $486,000 | -35.6% | 68,369 | +5.3% | 0.00% | – |
| Q1 2022 | $755,000 | -9.1% | 64,922 | -0.0% | 0.00% | – |
| Q4 2021 | $831,000 | -6.2% | 64,923 | 0.0% | 0.00% | – |
| Q3 2021 | $886,000 | -14.1% | 64,923 | +1.3% | 0.00% | – |
| Q2 2021 | $1,032,000 | -29.0% | 64,099 | -34.3% | 0.00% | – |
| Q1 2021 | $1,453,000 | +0.8% | 97,567 | +1.7% | 0.00% | – |
| Q4 2020 | $1,442,000 | +4.5% | 95,933 | +15.0% | 0.00% | – |
| Q3 2020 | $1,380,000 | +64.1% | 83,450 | +28.4% | 0.00% | – |
| Q2 2020 | $841,000 | +256.4% | 64,967 | +115.1% | 0.00% | – |
| Q1 2020 | $236,000 | -61.1% | 30,200 | -35.5% | 0.00% | – |
| Q4 2019 | $606,000 | – | 46,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,565,709 | $24,996,000 | 10.33% |
| Opaleye Management Inc. | 1,643,367 | $11,520,000 | 5.19% |
| INDUSTRY VENTURES, L.L.C. | 579,745 | $4,064,000 | 4.31% |
| Velan Capital Investment Management LP | 498,238 | $3,493,000 | 3.54% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 116,095 | $825,000 | 0.83% |
| HAMILTON LANE ADVISORS LLC | 264,366 | $1,853,000 | 0.72% |
| AIGH Capital Management LLC | 306,464 | $2,156,000 | 0.57% |
| Worth Venture Partners, LLC | 113,012 | $904,000 | 0.53% |
| Granite Point Capital Management, L.P. | 227,644 | $1,596,000 | 0.41% |
| Orbimed Advisors | 3,027,542 | $21,223,000 | 0.38% |